Evidence map›Paper›PMID 40996966›Full record

ArticlePloS one2025

The effect of temperature and nitrogen source modulation on Pseudomonas fluorescens AQP671 ice recrystallization inhibition activity.

Õnnela Luhila, Ildar Nisamedtinov, Toomas Paalme, Katrin Laos, Allan Olspert

Abstract read
In one paragraph

Article in PloS one, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Õnnela LuhilaDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, Tallinn, Estonia.ORCID https://orcid.org/0000-0001-5816-6239
Ildar NisamedtinovDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, Tallinn, Estonia.
Toomas PaalmeDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, Tallinn, Estonia.
Katrin LaosDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, Tallinn, Estonia.
Allan OlspertDepartment of Chemistry and Biotechnology, School of Science, Tallinn University of Technology, Tallinn, Estonia.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cold-adapted organisms have developed many different mechanisms to protect themselves from freezing temperatures. One of these mechanisms is ice recrystallization inhibition (IRI) activity. IRI refers to the ability of certain proteins and compounds to prevent the growth of ice crystals during freeze-thaw processes. The IRI activity of Pseudomonas fluorescens AQP 671 culture media was evaluated in relation to various nitrogen sources, incubation temperatures and pH conditions. The highest IRI activities were achieved with amino acids L-asparagine, L-proline, or L-valine, particularly under prolonged low-temperature cultivation. A rapid increase in IRI activity was observed during the first 24 hours, in response to cold shock, correlating with cell density. The activity was detected at temperatures below 15 °C, with the highest IRI activities achieved at 5-10 °C. The optimal pH range for high IRI activity was pH 6-8, and it was negatively affected by low (2-4) and high (10-12) pH values. These findings highlight the importance of both environmental conditions and nutrient composition in the expression of IRI activity in Pseudomonas fluorescens AQP671 culture media.

Indexed as

IceNitrogenPseudomonas fluorescensBacterial ProteinsCrystallizationCulture MediaHydrogen-Ion ConcentrationTemperatureBacterial ProteinsCulture MediaIceNitrogen

Identifiers

PMID40996966
PMCPMC12463234

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.